Uterine Cancer News and Research

RSS
When cancer starts in the uterus, it is called uterine cancer. The uterus is the pear-shaped organ in a woman's pelvis (the area below your stomach and in between your hip bones). The uterus, also called the womb, is where the baby grows when a woman is pregnant. The most common type of uterine cancer is also called endometrial cancer because it forms in the lining of your uterus, called the endometrium.

When uterine cancer is found early, treatment is most effective. The most common sign of uterine cancer is bleeding that is not normal for you because of when it happens or how heavy it is. This could mean bleeding, even a little bit, after you have gone through menopause; periods that are longer than seven days; bleeding between periods; or any other bleeding that is longer or heavier than is normal for you.

Other symptoms, such as pain or pressure in your pelvis, also may occur if you have uterine cancer. If you have any of these symptoms, talk to your doctor, nurse, or other health care professional right away. They may be caused by something other than cancer, but the only way to know is to see your health care professional.
HSD3B1 gene holds clues for predicting and treating endometrial cancer

HSD3B1 gene holds clues for predicting and treating endometrial cancer

Cancer patients have a greater risk for developing diabetes, study says

Cancer patients have a greater risk for developing diabetes, study says

Black people continue to bear a higher cancer burden even after steady decline in mortality rates

Black people continue to bear a higher cancer burden even after steady decline in mortality rates

Research suggests some solutions to combat cancer surgery-induced climate change

Research suggests some solutions to combat cancer surgery-induced climate change

Study finds racial and ethnic differences in rising uterine cancer mortality rates in the United States

Study finds racial and ethnic differences in rising uterine cancer mortality rates in the United States

Research shows alterations in transfer RNAs at the epigenetic level in cancer

Research shows alterations in transfer RNAs at the epigenetic level in cancer

Study identifies high-priority genes associated with uterine cancer that could be potential drug targets

Study identifies high-priority genes associated with uterine cancer that could be potential drug targets

Long-excluded uterine cancer patients are step closer to 9/11 benefits

Long-excluded uterine cancer patients are step closer to 9/11 benefits

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Combination of BMI and body shape predictor can help determine the risk of obesity-related cancers

Combination of BMI and body shape predictor can help determine the risk of obesity-related cancers

Researchers define genetic landscape of uterine leiomyosarcomas

Researchers define genetic landscape of uterine leiomyosarcomas

Proteomics analysis from aggressive human cancers can help identify potential therapeutic targets

Proteomics analysis from aggressive human cancers can help identify potential therapeutic targets

Gene screenings hold disease clues, but unexplained anomalies often raise fears

Gene screenings hold disease clues, but unexplained anomalies often raise fears

New breast cancer drug is safe and effective, can halt disease progression

New breast cancer drug is safe and effective, can halt disease progression

More than 40-year-old cancer mystery solved: Thanks to epigenetics

More than 40-year-old cancer mystery solved: Thanks to epigenetics

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Study: L-Grb2 has therapeutic efficacy in preclinical models of ovarian and uterine cancer

Newly discovered endometrial cancer biomarker enables early detection and treatment

Newly discovered endometrial cancer biomarker enables early detection and treatment

Many cells in human uterus carry 'cancer-driving' mutations that arise early in life

Many cells in human uterus carry 'cancer-driving' mutations that arise early in life

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Increased risk of uterine cancer linked to 24 gene variants

Increased risk of uterine cancer linked to 24 gene variants